TikTok peptide searches go blank for semaglutide and BPC 157

TikTok has begun returning a "no results found" page for searches on several peptide names, including semaglutide and BPC-157. The change to TikTok peptide searches was confirmed by The Verge on 20 October, after users flagged it on social media. Posts claiming a total ban on peptide content go further than the evidence shows. Searches for the word "peptides" still return videos, and there is no sign that published clips were removed. TikTok did not respond right away to a request for comment, The Verge reported, and the company has not published a policy change.

What changed in TikTok peptide searches

The Verge reported that searches for semaglutide, BPC-157, retatrutide, TB-500 and other named peptides now lead to an empty results page. Its senior news editor Richard Lawler tested the terms himself. He found that slight changes in spelling still surfaced videos, and that TikTok's own search suggestions offered working variants before he finished typing. The block is therefore narrow. It covers exact names in the search box, not the topic as a whole. A broad query for peptides still produces many short videos. The trade site YPulse reached the same view two days later, noting that search suggestions continued to list related terms. Neither outlet found evidence of accounts being removed, videos being taken down or the topic being barred from feeds.

The claim of a sweeping ban came from posts on X and from outlets that repeated them. One widely shared post said TikTok had banned all peptide content regardless of approval status. The Source, a music and culture site, described those claims as reports circulating online rather than confirmed fact. That distinction matters for anyone trying to judge the scale of the change. What can be verified is a set of blocked search terms on one platform, discovered by users and checked by a newsroom. What cannot be verified is the reason, the full list of blocked terms, or whether the step is permanent. TikTok has not explained the change in public or said whether more terms will follow.

Approved drugs and unapproved compounds in the same block

The blocked terms mix very different products. Semaglutide is the active ingredient in Ozempic and Wegovy, approved by the FDA for type 2 diabetes, weight management and several heart, kidney and liver uses. Retatrutide is an investigational Eli Lilly drug still in clinical trials, covered in our report that retatrutide posts the largest average weight loss yet in a phase 3 study. BPC-157 and TB-500 are not approved as medicines anywhere in the United States. They circulate mostly as products labelled for research use, which are not meant for people to take. A single search block that treats all four alike removes a way to find accurate information about an approved drug as well as promotion of untested compounds.

The Verge reported that searches for semaglutide, BPC-157, retatrutide, TB-500 and other named peptides now lead to an empty results page.

The FDA's page on bulk substances that may pose safety risks in compounding describes the gaps for BPC-157 directly. According to the agency, the compound may carry a risk of immune reactions for some routes of use and may have problems with peptide related impurities. The FDA says it lacks enough information to know whether BPC-157 would cause harm when given to people. The nomination of BPC-157 for that list was later withdrawn, so it now sits in a separate section of the page. In July, an FDA advisory committee voted 8 to 6, with one abstention, to recommend adding BPC-157 to the list of substances pharmacies may use for compounding. The vote is not binding, and the FDA has not acted on it.

Why platforms are under pressure on peptides

Peptide marketing has grown fast on short video apps, often through influencers who link to compounding pharmacies or research chemical sellers. The Verge noted that many of these products are of unknown quality and that users may not tell their doctors they are taking them. The search block arrived during a busy stretch for regulators. On 14 October, HHS and the FDA sent an interim policy on compounding with certain peptides to the White House budget office for review, according to the federal regulatory review dashboard at reginfo.gov. Its text has not been published. Separately, the FDA classified a Class II recall of compounded tirzepatide in October over doubts about sterility.

Platforms have used search blocks before when content raised health concerns. In 2025 TikTok blocked the SkinnyTok hashtag from search and sent users to eating disorder support resources, YPulse noted. A search block is a light tool. It does not stop creators from posting, and it does not affect videos that reach users through the main feed. It also invites workarounds, as the spelling variants show. The approach can still change behaviour at the margin by making a product harder to look up. For a deeper look at the regulatory status of one of the blocked terms, see our explainer on why BPC-157 sits outside the pharmacy.

What remains unclear

Several basic questions are still open. TikTok has not said which terms it blocked, whether the step was manual or automated, or whether it responds to any regulator, lawmaker or drug company request. Claims on social media that a drug maker pushed for the change are unproven, and no company has said it did. The block may also be temporary. Platforms often adjust search filters without notice, and the Verge test reflects one day. There is no public data on how many users searched for these terms before the change, or how many now reach the same videos through other spellings or through recommendations in their feed.

For patients, the practical status of the products has not changed. Semaglutide remains a prescription medicine available through licensed pharmacies. Retatrutide is not approved and is being tested only in clinical trials. BPC-157 and TB-500 remain unapproved, and products sold online under those names carry the quality and counterfeit risks the FDA has described. The block on TikTok peptide searches does not alter any of that. Anyone weighing one of these products should speak with a licensed clinician first. Our safety desk follows the federal peptide policy and will note any statement from TikTok. This story is for research and news purposes and is not medical advice.

Conclusion

The change to TikTok peptide searches is real but narrow. Exact names such as semaglutide and BPC-157 return nothing, while the broad topic, published videos and simple spelling variants remain visible. TikTok has not explained the move. The status of the products is unchanged: one is an approved prescription drug, one is still in trials, and others remain unapproved compounds that the FDA says lack basic human safety data.